BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Das M, Saikia BJ, Sharma SK, Sekhon GS, Mahanta J, Phukan RK. p16 hypermethylation: A biomarker for increased esophageal cancer susceptibility in high incidence region of North East India. Tumor Biol 2015;36:1627-42. [DOI: 10.1007/s13277-014-2762-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Bhushan A, Singh A, Kapur S, Borthakar BB, Sharma J, Rai AK, Kataki AC, Saxena S. Identification and Validation of Fibroblast Growth Factor 12 Gene as a Novel Potential Biomarker in Esophageal Cancer Using Cancer Genomic Datasets. OMICS 2017;21:616-31. [PMID: 29049013 DOI: 10.1089/omi.2017.0116] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
2 Baruah B, Dutta MP, Bhattacharyya DK. Identification of ESCC potential biomarkers using biclustering algorithms. Gene Reports 2022. [DOI: 10.1016/j.genrep.2022.101563] [Reference Citation Analysis]
3 Dong Y, Yi X, Yujie Z, Huixia Z, Yan C. Relationship between the Methylation of Folic Acid Metabolism-Related Genes and the Incidence and Prognosis of Esophageal Cancer among Ethnic Kazakhs. J Cancer 2018;9:2865-75. [PMID: 30123355 DOI: 10.7150/jca.25270] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
4 Singh V, Singh LC, Vasudevan M, Chattopadhyay I, Borthakar BB, Rai AK, Phukan RK, Sharma J, Mahanta J, Kataki AC, Kapur S, Saxena S. Esophageal Cancer Epigenomics and Integrome Analysis of Genome-Wide Methylation and Expression in High Risk Northeast Indian Population. OMICS: A Journal of Integrative Biology 2015;19:688-99. [DOI: 10.1089/omi.2015.0121] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
5 Amorim CA, De Souza LP, Moreira JP, Luiz RR, De V Carneiro AJ, De Souza HSP. Geographic distribution and time trends of esophageal cancer in Brazil from 2005 to 2015. Mol Clin Oncol 2019;10:631-8. [PMID: 31086670 DOI: 10.3892/mco.2019.1842] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
6 Wang S, Pan D, Su M, Huang G, Sun G. Moderately high folate level may offset the effects of aberrant DNA methylation of P16 and P53 genes in esophageal squamous cell carcinoma and precancerous lesions. Genes Nutr 2020;15:18. [PMID: 32993492 DOI: 10.1186/s12263-020-00677-x] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Pan D, Su M, Huang G, Luo P, Zhang T, Fu L, Wei J, Wang S, Sun G. MTHFR C677T genetic polymorphism in combination with serum vitamin B2, B12 and aberrant DNA methylation of P16 and P53 genes in esophageal squamous cell carcinoma and esophageal precancerous lesions: a case-control study. Cancer Cell Int 2019;19:288. [PMID: 31754346 DOI: 10.1186/s12935-019-1012-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
8 Qin Y, Zhou J, Fan Z, Gu J, Li X, Lin D, Deng D, Wei W. Evaluation of the Impact of Intratumoral Heterogeneity of Esophageal Cancer on Pathological Diagnosis and P16 Methylation and the Representativity of Endoscopic Biopsy. Front Oncol 2021;11:683876. [PMID: 34485122 DOI: 10.3389/fonc.2021.683876] [Reference Citation Analysis]
9 Das M, Sharma SK, Sekhon GS, Mahanta J, Phukan RK, Jalan BK. p16 gene silencing along with p53 single-nucleotide polymorphism and risk of esophageal cancer in Northeast India.Tumour Biol. 2017;39:1010428317698384. [PMID: 28459370 DOI: 10.1177/1010428317698384] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
10 Hull R, Mbele M, Makhafola T, Hicks C, Wang SM, Reis RM, Mehrotra R, Mkhize-Kwitshana Z, Hussain S, Kibiki G, Bates DO, Dlamini Z. A multinational review: Oesophageal cancer in low to middle-income countries. Oncol Lett 2020;20:42. [PMID: 32802164 DOI: 10.3892/ol.2020.11902] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Gao D, Herman JG, Guo M. The clinical value of aberrant epigenetic changes of DNA damage repair genes in human cancer. Oncotarget 2016;7:37331-46. [PMID: 26967246 DOI: 10.18632/oncotarget.7949] [Cited by in Crossref: 51] [Cited by in F6Publishing: 46] [Article Influence: 12.8] [Reference Citation Analysis]
12 Guo M, Peng Y, Gao A, Du C, Herman JG. Epigenetic heterogeneity in cancer. Biomark Res 2019;7:23. [PMID: 31695915 DOI: 10.1186/s40364-019-0174-y] [Cited by in Crossref: 42] [Cited by in F6Publishing: 33] [Article Influence: 14.0] [Reference Citation Analysis]
13 Chen Z, Ren Y, Du XL, Yang J, Shen Y, Li S, Wu Y, Lv M, Dong D, Li E, Li W, Liu P, Yang J, Yi M. Incidence and survival differences in esophageal cancer among ethnic groups in the United States. Oncotarget 2017;8:47037-51. [PMID: 28410201 DOI: 10.18632/oncotarget.16694] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 6.0] [Reference Citation Analysis]